Literature DB >> 9690553

The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma.

J E Marks1, J L Phillips, H R Menck.   

Abstract

BACKGROUND: The development of nasopharyngeal carcinoma reflects interactions of genetics, diet, and viral agents. It is more common in Asians than non-Asians, with different characteristic histologic types. This study examined nasopharyngeal carcinoma in the U.S. as a function of patient origin and histology.
METHODS: The data were from the National Cancer Data Base (NCDB). The 5069 nasopharyngeal carcinoma cases were grouped by histologic type: keratinizing squamous cell, nonkeratinizing, and undifferentiated carcinoma. Patient origin was derived from race, Hispanic ethnicity, and place of birth.
RESULTS: World Health Organization (WHO) type 1 keratinizing squamous cell carcinomas comprised 75% of the U.S. nasopharyngeal carcinoma cases and were found most often in U.S.-born, non-Hispanic whites. WHO-2 nonkeratinizing and WHO-3 undifferentiated carcinomas of the nasopharnyx comprised the remaining 25% of nasopharyngeal carcinomas and were more common in Asians. Histologic composition varied for each of the 12 patient origin groups in the study and correlated with survival after treatment with ionizing radiation. Asians had the highest proportion of radioresponsive WHO-2 nonkeratinizing and WHO-3 undifferentiated carcinomas of the nasopharynx and better survival than African-Americans and Hispanic and non-Hispanic whites, who had the greatest number of the less radioresponsive keratinizing squamous cell carcinomas of the nasopharynx. The 5-year relative survival was 65% for the nonkeratinizing and undifferentiated carcinomas of the nasopharynx and 37% for the keratinizing variety.
CONCLUSIONS: The survival rate of the patient origin groups correlated with the histologic composition of their nasopharyngeal carcinomas. Those with the highest proportion of radioresponsive nonkeratinizing and undifferentiated carcinomas had the best survival.

Entities:  

Mesh:

Year:  1998        PMID: 9690553     DOI: 10.1002/(sici)1097-0142(19980801)83:3<582::aid-cncr29>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  61 in total

1.  Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal.

Authors:  Breda Eduardo; Catarino Raquel; Medeiros Rui
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-08       Impact factor: 2.503

2.  Update on nasopharyngeal carcinoma.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2007-11-27

3.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

4.  DNA repair capacity in lymphocytes of nasopharyngeal cancer patients.

Authors:  Norbert H Kleinsasser; Barbara C Wallner; Christiane Wagner; Ernst R Kastenbauer; Ulrich A Harréus
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-12-24       Impact factor: 2.503

5.  Challenges of managing nasopharyngeal carcinoma in a developing country.

Authors:  Olawunmi Fatusi; Olubunmi Akinpelu; Yemisi Amusa
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

6.  Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging.

Authors:  Sheng-Chieh Chan; Shu-Hang Ng; Joseph Tung-Chieh Chang; Chien-Yu Lin; Yen-Chao Chen; Yu-Chen Chang; Cheng-Lung Hsu; Hung-Ming Wang; Chun-Ta Liao; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-19       Impact factor: 9.236

Review 7.  Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.

Authors:  Josephine Chou; Yu-Ching Lin; Jae Kim; Liang You; Zhidong Xu; Biao He; David M Jablons
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

Review 8.  Does East meet West? Towards a unified vision of the management of Nasopharyngeal carcinoma.

Authors:  Elaine Johanna Limkin; Pierre Blanchard
Journal:  Br J Radiol       Date:  2019-05-31       Impact factor: 3.039

9.  Notch1 signaling is activated in cells expressing embryonic stem cell proteins in human primary nasopharyngeal carcinoma.

Authors:  Yue Zhang; Jianhua Peng; Huxiang Zhang; Yi Zhu; Li Wan; Jianfu Chen; Xiaoyun Chen; Renyu Lin; He Li; Xiaoou Mao; Kunlin Jin
Journal:  J Otolaryngol Head Neck Surg       Date:  2010-04

10.  Current management strategy of nasopharyngeal carcinoma.

Authors:  William I Wei; Dora L W Kwong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.